Pfizer To Buy King Pharma For $3.6 billion In Order to Strengthen Pain Franchise

Pfizer will gain access to King's specialized portfolio of medications for acute, severe pain and to Remoxy, which could catapult the Big Pharma into the controversial but promising field of tamper-resistant opioid medications.